Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added. Notices about government funding and the prior revision (v3.4.1) were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice with operating status guidance was added, and the page now shows a revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display option and updated metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No study content, eligibility criteria, or results were modified.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing sites in Massachusetts, Michigan, and Tennessee, replacing the previous separate location headers. The page revision is v3.3.3.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.